Loading…
Wednesday, June 26 • 4:15pm - 5:30pm
#381: A New Path Forward for Using Decentralized Clinical Trials

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Forum
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-19-713-L04-P; CME 1.25; IACET 1.25; RN 1.25

Barriers are hindering the widespread use of decentralized clinical trials. However, new recommendations developed by CTTI offer new approaches to improve recruitment and retention, participant diversity, and the research experience for patients.

Learning Objectives

Describe proven methods for executing decentralized clinical trials through telemedicine and mobile healthcare providers; Discuss actionable recommendations for navigating state medical licensing laws and issues with drug supply chain of custody; Identify the broad continuum of hybrid protocol designs possibilities for implementing decentralized clinical trials.

Chair

Penny Randall, MD

Speaker

Panelist
Laura Byrnes Podolsky, JD, MPH

Panelist
Gail Adinamis

Panelist
Michael O'Brien, CPA



Speakers
avatar for Gail Adinamis

Gail Adinamis

CEO, GlobalCare Clinical Trials, LLC
Ms Adinamis has >35 yrs of global clinical trials experience including tenures at Abbott and Astellas. She established & headed clinical trials divisions for 3 national home infusion companies then started an independent ambulant care service company for clinical trials in 2004 where... Read More →
avatar for Michael O'Brien

Michael O'Brien

Chief Strategy Officer, The Avoca Group
Michael brings more than 30 years of executive management experience in the life sciences and information technology industries. Michael is currently the Chief Strategy Officer for The Avoca Group. For the prior 5 years, Michael has been an early pioneer in the development and support... Read More →
LP

Laura Podolsky

General Counsel, Science 37, Inc.
Laura is a health care lawyer focusing on novel healthcare technologies. She has served as Science 37's General Counsel since its founding, assisting the company in navigating legal and regulatory issues surrounding decentralized clinical trials. She earned her JD from the UCLA School... Read More →
avatar for Penny Randall

Penny Randall

Vice President and Head, CNS Center of Excellence, IQVIA
Dr. Randall is Vice President and Head of the CNS Center of Excellence at IQVIA. Her scientific focus is on optimizing trial design and implementation to minimize the risk of inconclusive trials. She is also interested in leveraging disruptive technologies to modernize and accelerate... Read More →


Wednesday June 26, 2019 4:15pm - 5:30pm
Room 10 San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA